# FL genes

## Origins of FL genes
```mermaid
---
config:
  sankey:
    showValues: false
    linkColor: target
    width: 800
    height: 1000
    nodeAlignment: right
---
sankey-beta
Okosun 2016, FL Tier 1, 2
Russler-germain 2023, FL Tier 1, 1
Russler-germain 2023, FL Tier 2, 19
Krysiak 2017, FL Tier 1, 17
Krysiak 2017, FL Tier 2, 5
Morin 2011, FL Tier 1, 14
Morin 2011, FL Tier 2, 1
Pasqualucci 2011, FL Tier 1, 2
Hubschmann 2021, FL Tier 1, 2
Hubschmann 2021, FL Tier 2, 15
FL, WGS, 2
WGS, Okosun 2016, 2
FL, exome, 20
exome, Russler-germain 2023, 20
FL, exome, 2
exome, Pasqualucci 2011, 2
FL, WGS, 17
WGS, Hubschmann 2021, 17
FL, exome, 22
exome, Krysiak 2017, 22
FL, RNA-seq/WGS, 15
RNA-seq/WGS, Morin 2011, 15
```

## Tier 1 FL genes

### *66 total*

|          Gene          |  Tier   | Relevant references                                                                                     |
|:----------------------:|:-------:|:--------------------------------------------------------------------------------------------------------|
|      [ACTB](ACTB)      | 1, aSHM | Lohr et al. 2012; Wienand et al. 2019                                                                 |
|    [ARID1A](ARID1A)    |    1    | Zhang et al. 2013; Wienand et al. 2019; Love et al. 2012; Krysiak et al. 2017; Rossi et al. 2012      |
|   [ATP6AP1](ATP6AP1)   |    1    | Okosun et al. 2016                                                                                    |
|  [ATP6V1B2](ATP6V1B2)  |    1    | Okosun et al. 2016                                                                                    |
|       [B2M](B2M)       |    1    | Morin et al. 2011; Pararajalingam et al. 2020; Reichel et al. 2015                                    |
|      [BCL2](BCL2)      | 1, aSHM | Sarkozy et al. 2021; Tanaka et al. 1992; Burkhardt et al. 2022; Morin et al. 2011                     |
|      [BCL6](BCL6)      | 1, aSHM | Morin et al. 2011; Love et al. 2012                                                                   |
|     [BCL7A](BCL7A)     | 1, aSHM | Reichel et al. 2015; Grande et al. 2019; Krysiak et al. 2017; Arthur et al. 2018                      |
|     [BIRC6](BIRC6)     |    1    | Sarkozy et al. 2021; Reddy et al. 2017                                                                |
|      [BTG1](BTG1)      | 1, aSHM | Sarkozy et al. 2021; Burkhardt et al. 2022; Morin et al. 2011                                         |
|      [BTG2](BTG2)      | 1, aSHM | Love et al. 2012; Morin et al. 2011                                                                   |
|       [BTK](BTK)       |    1    | Krysiak et al. 2017; Albuquerque et al. 2017                                                          |
|    [CARD11](CARD11)    |    1    | Yan et al. 2012; Lenz et al. 2008; Morin et al. 2011; Panea et al. 2019; Wu et al. 2016               |
|     [CCND3](CCND3)     |    1    | Desch et al. 2020; Jallades et al. 2017; Richter et al. 2012; Morin et al. 2011                       |
|      [CD83](CD83)      | 1, aSHM | Russler-Germain et al. 2023; Panea et al. 2019; Duns et al. 2021; Morin et al. 2013                   |
|    [CREBBP](CREBBP)    |    1    | Duns et al. 2021; Laura Pasqualucci, Dominguez-Sola, et al. 2011; Love et al. 2012; Parry et al. 2013 |
|      [CTSS](CTSS)      |    1    | Bararia et al. 2020                                                                                   |
|      [DTX1](DTX1)      | 1, aSHM | Rossi et al. 2012; Panea et al. 2019; Gomez et al. 2023; Schmitz et al. 2018                          |
|      [EBF1](EBF1)      | 1, aSHM | Reichel et al. 2015; Thomas et al. 2023; Bohle et al. 2013                                            |
|    [EEF1A1](EEF1A1)    |    1    | Reichel et al. 2015; Hübschmann et al. 2021                                                           |
|     [EP300](EP300)     |    1    | Laura Pasqualucci, Dominguez-Sola, et al. 2011; Panea et al. 2019; Rossi et al. 2012                  |
|      [EZH2](EZH2)      |    1    | Morin et al. 2010; Love et al. 2012; Mottok et al. 2019                                               |
|       [FAS](FAS)       |    1    | Scholl et al. 2007; Spina et al. 2016                                                                 |
|     [FOXO1](FOXO1)     |    1    | Morin et al. 2011; Schmitz et al. 2012; Duns et al. 2021                                              |
|     [GNA13](GNA13)     |    1    | Love et al. 2012; Morin et al. 2011; Reichel et al. 2015                                              |
|     [GNAI2](GNAI2)     |    1    | Morin et al. 2013; Grande et al. 2019                                                                 |
|  [HIST1H1B](HIST1H1B)  | 1, aSHM | Sarkozy et al. 2021; Chapuy et al. 2018; Krysiak et al. 2017                                          |
|  [HIST1H1C](HIST1H1C)  | 1, aSHM | Morin et al. 2011; Panea et al. 2019                                                                  |
|  [HIST1H1D](HIST1H1D)  | 1, aSHM | Krysiak et al. 2017; Morin et al. 2013; Jallades et al. 2017                                          |
|  [HIST1H1E](HIST1H1E)  | 1, aSHM | Reichel et al. 2015; Morin et al. 2013; Krysiak et al. 2017; Grande et al. 2019                       |
| [HIST1H2AC](HIST1H2AC) | 1, aSHM | Krysiak et al. 2017; Morin et al. 2013                                                                |
| [HIST1H2AG](HIST1H2AG) | 1, aSHM | Krysiak et al. 2017; Panea et al. 2019; Morin et al. 2013; Rossi et al. 2012                          |
| [HIST1H2AM](HIST1H2AM) | 1, aSHM | Panea et al. 2019; Krysiak et al. 2017                                                                |
| [HIST1H2BC](HIST1H2BC) | 1, aSHM | Mottok et al. 2019; Krysiak et al. 2017; Reddy et al. 2017                                            |
| [HIST1H2BD](HIST1H2BD) | 1, aSHM | Krysiak et al. 2017                                                                                   |
| [HIST1H2BG](HIST1H2BG) | 1, aSHM | Krysiak et al. 2017                                                                                   |
|  [HIST1H3B](HIST1H3B)  | 1, aSHM | Zhang et al. 2013; Reichel et al. 2015                                                                |
|  [HIST1H3G](HIST1H3G)  | 1, aSHM | Krysiak et al. 2017                                                                                   |
|     [HVCN1](HVCN1)     |    1    | Krysiak et al. 2017                                                                                   |
|      [IRF4](IRF4)      | 1, aSHM | Mottok et al. 2019; Morin et al. 2011                                                                 |
|      [IRF8](IRF8)      | 1, aSHM | Panea et al. 2019; Morin et al. 2011; Mottok et al. 2019                                              |
|     [ITPKB](ITPKB)     | 1, aSHM | Schmitz et al. 2018; Reichel et al. 2015                                                              |
|      [KLF2](KLF2)      | 1, aSHM | Laura Pasqualucci, Trifonov, et al. 2011; Desch et al. 2020; Jallades et al. 2017                     |
|     [KLHL6](KLHL6)     | 1, aSHM | Panea et al. 2019; Ganapathi et al. 2016; Morin et al. 2011                                           |
|     [KMT2D](KMT2D)     |    1    | Rossi et al. 2012; Desch et al. 2020; Morin et al. 2011; Beà et al. 2013; Grande et al. 2019          |
|       [LTB](LTB)       | 1, aSHM | Desch et al. 2020; Chapuy et al. 2018; Panea et al. 2019                                              |
|    [MAP2K1](MAP2K1)    |    1    | Shin et al. 2015; Louissaint et al. 2016                                                              |
|     [MEF2B](MEF2B)     | 1, aSHM | Beà et al. 2013; Morin et al. 2011                                                                    |
|     [MEF2C](MEF2C)     | 1, aSHM | Arthur et al. 2018                                                                                    |
|      [PCLO](PCLO)      |    1    | Lohr et al. 2012                                                                                      |
|      [PIM1](PIM1)      | 1, aSHM | Duns et al. 2021; L. Pasqualucci et al. 2001; Burkhardt et al. 2022                                   |
|   [POU2AF1](POU2AF1)   |    1    | Krysiak et al. 2017                                                                                   |
|    [POU2F2](POU2F2)    |    1    | Zhang et al. 2013; Krysiak et al. 2017                                                                |
|     [PTPRD](PTPRD)     |    1    | Spina et al. 2016                                                                                     |
|     [RRAGC](RRAGC)     |    1    | Okosun et al. 2016                                                                                    |
|     [S1PR2](S1PR2)     | 1, aSHM | Morin et al. 2011; Muppidi et al. 2014                                                                |
|      [SGK1](SGK1)      | 1, aSHM | Morin et al. 2011; Duns et al. 2021                                                                   |
|   [SMARCA4](SMARCA4)   |    1    | Zhang et al. 2013; Nadeu et al. 2020; Krysiak et al. 2017; Richter et al. 2012                        |
|     [SOCS1](SOCS1)     | 1, aSHM | Morin et al. 2011; Weniger et al. 2006                                                                |
|     [STAT6](STAT6)     |    1    | Yildiz et al. 2015; Ritz et al. 2009                                                                  |
|   [TBL1XR1](TBL1XR1)   |    1    | Rossi et al. 2012; Mareschal et al. 2016                                                              |
|    [TMSB4X](TMSB4X)    | 1, aSHM | Albuquerque et al. 2017                                                                               |
|   [TNFAIP3](TNFAIP3)   |    1    | Schmitz et al. 2009; Compagno et al. 2009; Rossi et al. 2011                                          |
|  [TNFRSF14](TNFRSF14)  |    1    | Cheung et al. 2010; Spina et al. 2016                                                                 |
|      [TP53](TP53)      |    1    | Wilda et al. 2004; Rossi et al. 2012; Beà et al. 2013; Tiacci et al. 2018; Morin et al. 2011          |
|     [VMA21](VMA21)     |    1    | Hübschmann et al. 2021                                                                                |

## Tier 2 FL genes

### *50 total*

|          Gene          |  Tier   | Relevant references                                                                             |
|:----------------------:|:-------:|:------------------------------------------------------------------------------------------------|
|      [ABL2](ABL2)      |    2    | Russler-Germain et al. 2023                                                                   |
|     [ACTG1](ACTG1)     | 2, aSHM | Hübschmann et al. 2021; Spina et al. 2016; Desch et al. 2020                                  |
|   [ATP6V1A](ATP6V1A)   |    2    | Hübschmann et al. 2021                                                                        |
|     [BCL10](BCL10)     |    2    | Spina et al. 2016; Russler-Germain et al. 2023; Morin et al. 2011                             |
| [CCDC42BPB](CCDC42BPB) |    2    | Hübschmann et al. 2021                                                                        |
|      [CD70](CD70)      |    2    | Morin et al. 2011; Russler-Germain et al. 2023                                                |
|     [CD79B](CD79B)     |    2    | Morin et al. 2011; Panea et al. 2019                                                          |
|      [CILP](CILP)      |    2    | Russler-Germain et al. 2023                                                                   |
|     [CPNE8](CPNE8)     |    2    | Hübschmann et al. 2021                                                                        |
|     [CXCR4](CXCR4)     | 2, aSHM | Krysiak et al. 2017; Panea et al. 2019; Khodabakhshi et al. 2012                              |
|    [CYP2A6](CYP2A6)    |    2    | Russler-Germain et al. 2023                                                                   |
|     [DDX3X](DDX3X)     |    2    | Schmitz et al. 2018, 2012; Mottok et al. 2019                                                 |
|     [DHX15](DHX15)     |    2    | Hübschmann et al. 2021                                                                        |
|     [DUSP2](DUSP2)     | 2, aSHM | Morin et al. 2013; Duns et al. 2021                                                           |
|      [EGR1](EGR1)      |    2    | Krysiak et al. 2017; Rossi et al. 2012; Reichel et al. 2015                                   |
|      [FZR1](FZR1)      |    2    | Hübschmann et al. 2021                                                                        |
|      [GBP7](GBP7)      |    2    | Russler-Germain et al. 2023                                                                   |
|      [GRM6](GRM6)      |    2    | Russler-Germain et al. 2023                                                                   |
| [HIST1H2BM](HIST1H2BM) | 2, aSHM | Krysiak et al. 2017                                                                           |
|  [HIST1H3I](HIST1H3I)  | 2, aSHM | Panea et al. 2019; Krysiak et al. 2017                                                        |
|     [HLA-B](HLA-B)     |    2    | Wienand et al. 2019                                                                           |
|    [HNRNPD](HNRNPD)    |    2    |                                                                                                 |
|     [IGLL5](IGLL5)     | 2, aSHM | Russler-Germain et al. 2023; Desch et al. 2020; Panea et al. 2019                             |
|       [JUP](JUP)       |    2    | Hübschmann et al. 2021                                                                        |
|   [KIR3DL1](KIR3DL1)   |    2    | Russler-Germain et al. 2023                                                                   |
|    [LAPTM5](LAPTM5)    |    2    | Hübschmann et al. 2021                                                                        |
|    [MAGEC1](MAGEC1)    |    2    | Russler-Germain et al. 2023                                                                   |
|    [MAP7D1](MAP7D1)    |    2    | Russler-Germain et al. 2023                                                                   |
|     [MGEA5](MGEA5)     |    2    | Hübschmann et al. 2021                                                                        |
|     [MKI67](MKI67)     |    2    | Russler-Germain et al. 2023; Schmitz et al. 2012                                              |
|       [MYC](MYC)       | 2, aSHM | Johnston and Carroll 1992; L. Pasqualucci et al. 2001; Jallades et al. 2017; Duns et al. 2021 |
|    [MYCBP2](MYCBP2)    |    2    | Hübschmann et al. 2021                                                                        |
|     [MYD88](MYD88)     |    2    | Ngo et al. 2011; Yan et al. 2012                                                              |
|    [NFKBIA](NFKBIA)    |    2    | Wienand et al. 2019; Russler-Germain et al. 2023; Lake et al. 2009                            |
|     [OR8H2](OR8H2)     |    2    | Russler-Germain et al. 2023                                                                   |
|     [P2RY8](P2RY8)     |    2    | Muppidi et al. 2014; Lohr et al. 2012                                                         |
|     [PDS5B](PDS5B)     |    2    | Morin et al. 2013; Hübschmann et al. 2021                                                     |
|     [PPP4C](PPP4C)     |    2    | Hübschmann et al. 2021                                                                        |
|     [PRKDC](PRKDC)     |    2    | Schmitz et al. 2018; Hübschmann et al. 2021                                                   |
|       [PZP](PZP)       |    2    | Russler-Germain et al. 2023                                                                   |
|      [RBM6](RBM6)      |    2    | Hübschmann et al. 2021                                                                        |
|     [SESN1](SESN1)     |    2    | Oricchio et al. 2017                                                                          |
|   [SHROOM3](SHROOM3)   |    2    | Russler-Germain et al. 2023                                                                   |
|     [SRRM2](SRRM2)     |    2    | Morin et al. 2013; Russler-Germain et al. 2023                                                |
|     [STAB2](STAB2)     |    2    | Russler-Germain et al. 2023                                                                   |
|   [TMEM30A](TMEM30A)   |    2    | Morin et al. 2011                                                                             |
|      [TPP1](TPP1)      |    2    | Hübschmann et al. 2021                                                                        |
|     [XIRP2](XIRP2)     |    2    | Russler-Germain et al. 2023                                                                   |
|   [ZC3H12A](ZC3H12A)   |    2    | Arthur et al. 2018                                                                            |
|    [ZNF608](ZNF608)    |    2    | Zhang et al. 2013; Krysiak et al. 2017                                                        |

# References

<div id="refs" class="references csl-bib-body hanging-indent">

<div id="ref-albuquerqueEnhancingKnowledgeDiscovery2017a"
class="csl-entry">

Albuquerque, Marco A., Bruno M. Grande, Elie J. Ritch, Prasath
Pararajalingam, Selin Jessa, Martin Krzywinski, Jasleen K. Grewal,
Sohrab P. Shah, Paul C. Boutros, and Ryan D. Morin. 2017. “Enhancing
Knowledge Discovery from Cancer Genomics Data with Galaxy.”
*GigaScience* 6 5: 1–13. <https://doi.org/10.1093/gigascience/gix015>.

</div>

<div id="ref-arthurGenomewideDiscoverySomatic2018" class="csl-entry">

Arthur, Sarah E., Aixiang Jiang, Bruno M. Grande, Miguel Alcaide, Razvan
Cojocaru, Christopher K. Rushton, Anja Mottok, et al. 2018. “Genome-Wide
Discovery of Somatic Regulatory Variants in Diffuse Large <span
class="nocase">B-cell</span> Lymphoma.” *Nature Communications* 9 1:
4001. <https://doi.org/10.1038/s41467-018-06354-3>.

</div>

<div id="ref-barariaCathepsinAlterationsInduce2020c" class="csl-entry">

Bararia, Deepak, Johannes A. Hildebrand, Sebastian Stolz, Sarah Haebe,
Stefan Alig, Christopher P. Trevisani, Francisco Osorio-Barrios, et al.
2020. “Cathepsin S Alterations Induce a Tumor-Promoting Immune
Microenvironment in Follicular Lymphoma.” *Cell Reports* 31 5: 107522.
<https://doi.org/10.1016/j.celrep.2020.107522>.

</div>

<div id="ref-beaLandscapeSomaticMutations2013" class="csl-entry">

Beà, Sílvia, Rafael Valdés-Mas, Alba Navarro, Itziar Salaverria, David
Martín-Garcia, Pedro Jares, Eva Giné, et al. 2013. “Landscape of Somatic
Mutations and Clonal Evolution in Mantle Cell Lymphoma.” *Proceedings of
the National Academy of Sciences* 110 45: 18250–55.
<https://doi.org/10.1073/pnas.1314608110>.

</div>

<div id="ref-bohleRoleEarlyBcell2013" class="csl-entry">

Bohle, V., C. Döring, M.-L. Hansmann, and R. Küppers. 2013. “Role of
Early <span class="nocase">B-cell</span> Factor 1 EBF1 in Hodgkin
Lymphoma.” *Leukemia* 27 3: 671–79.
<https://doi.org/10.1038/leu.2012.280>.

</div>

<div id="ref-burkhardtClinicalRelevanceMolecular2022b"
class="csl-entry">

Burkhardt, Birgit, Ulf Michgehl, Jonas Rohde, Tabea Erdmann, Philipp
Berning, Katrin Reutter, Marius Rohde, et al. 2022. “Clinical Relevance
of Molecular Characteristics in Burkitt Lymphoma Differs According to
Age.” *Nature Communications* 13 1: 3881.
<https://doi.org/10.1038/s41467-022-31355-8>.

</div>

<div id="ref-chapuyMolecularSubtypesDiffuse2018b" class="csl-entry">

Chapuy, Bjoern, Chip Stewart, Andrew J. Dunford, Jaegil Kim, Atanas
Kamburov, Robert A. Redd, Mike S. Lawrence, et al. 2018. “Molecular
Subtypes of Diffuse Large B Cell Lymphoma Are Associated with Distinct
Pathogenic Mechanisms and Outcomes.” *Nature Medicine* 24 5: 679–90.
<https://doi.org/10.1038/s41591-018-0016-8>.

</div>

<div id="ref-cheungAcquiredTNFRSF14Mutations2010a" class="csl-entry">

Cheung, K.-John J., Nathalie A. Johnson, Joslynn G. Affleck, Tesa
Severson, Christian Steidl, Susana Ben-Neriah, Jacqueline Schein, et al.
2010. “Acquired TNFRSF14 Mutations in Follicular Lymphoma Are Associated
with Worse Prognosis.” *Cancer Research* 70 22: 9166–74.
<https://doi.org/10.1158/0008-5472.CAN-10-2460>.

</div>

<div id="ref-compagnoMutationsMultipleGenes2009a" class="csl-entry">

Compagno, Mara, Wei Keat Lim, Adina Grunn, Subhadra V. Nandula, Manisha
Brahmachary, Qiong Shen, Francesco Bertoni, et al. 2009. “Mutations of
Multiple Genes Cause Deregulation of <span
class="nocase">NF-kappaB</span> in Diffuse Large <span
class="nocase">B-cell</span> Lymphoma.” *Nature* 459 7247: 717–21.
<https://doi.org/10.1038/nature07968>.

</div>

<div id="ref-deschGenotypingCirculatingTumor2020" class="csl-entry">

Desch, Ann-Kathrin, Kristin Hartung, Ante Botzen, Alexander Brobeil,
Mathias Rummel, Lars Kurch, Thomas Georgi, et al. 2020. “Genotyping
Circulating Tumor DNA of Pediatric Hodgkin Lymphoma.” *Leukemia* 34 1:
151–66. <https://doi.org/10.1038/s41375-019-0541-6>.

</div>

<div id="ref-dunsCharacterizationDLBCLPMBL2021b" class="csl-entry">

Duns, Gerben, Elena Viganò, Daisuke Ennishi, Clementine Sarkozy, Stacy
S. Hung, Elizabeth Chavez, Katsuyoshi Takata, et al. 2021.
“Characterization of DLBCL with a PMBL Gene Expression Signature.”
*Blood* 138 2: 136–48. <https://doi.org/10.1182/blood.2020007683>.

</div>

<div id="ref-ganapathiGeneticLandscapeDural2016" class="csl-entry">

Ganapathi, Karthik A., Vaidehi Jobanputra, Fabio Iwamoto, Preti Jain,
Jinli Chen, Luciano Cascione, Odelia Nahum, et al. 2016. “The Genetic
Landscape of Dural Marginal Zone Lymphomas.” *Oncotarget* 7 28:
43052–61. <https://doi.org/10.18632/oncotarget.9678>.

</div>

<div id="ref-gomezUltraDeepSequencingReveals2023" class="csl-entry">

Gomez, Felicia, Bryan Fisk, Joshua F. McMichael, Matthew Mosior,
Jennifer A. Foltz, Zachary L. Skidmore, Eric J. Duncavage, et al. 2023.
“Ultra-Deep Sequencing Reveals the Mutational Landscape of Classical
Hodgkin Lymphoma.” *Cancer Research Communications* 3 11: 2312–30.
<https://doi.org/10.1158/2767-9764.CRC-23-0140>.

</div>

<div id="ref-grandeGenomewideDiscoverySomatic2019" class="csl-entry">

Grande, Bruno M., Daniela S. Gerhard, Aixiang Jiang, Nicholas B. Griner,
Jeremy S. Abramson, Thomas B. Alexander, Hilary Allen, et al. 2019.
“Genome-Wide Discovery of Somatic Coding and Noncoding Mutations in
Pediatric Endemic and Sporadic Burkitt Lymphoma.” *Blood* 133 12:
1313–24. <https://doi.org/10.1182/blood-2018-09-871418>.

</div>

<div id="ref-hubschmannMutationalMechanismsShaping2021b"
class="csl-entry">

Hübschmann, Daniel, Kortine Kleinheinz, Rabea Wagener, Stephan H.
Bernhart, Cristina López, Umut H. Toprak, Stephanie Sungalee, et al.
2021. “Mutational Mechanisms Shaping the Coding and Noncoding Genome of
Germinal Center Derived <span class="nocase">B-cell</span> Lymphomas.”
*Leukemia* 35 7: 2002–16.
<https://doi.org/10.1038/s41375-021-01251-z>.

</div>

<div id="ref-jalladesExomeSequencingIdentifies2017" class="csl-entry">

Jallades, Laurent, Lucile Baseggio, Pierre Sujobert, Sarah Huet, Kaddour
Chabane, Evelyne Callet-Bauchu, Aurélie Verney, et al. 2017. “Exome
Sequencing Identifies Recurrent BCOR Alterations and the Absence of
KLF2, TNFAIP3 and MYD88 Mutations in Splenic Diffuse Red Pulp Small
<span class="nocase">B-cell</span> Lymphoma.” *Haematologica* 102 10:
1758–66. <https://doi.org/10.3324/haematol.2016.160192>.

</div>

<div id="ref-johnstonCmycHypermutationBurkitt1992" class="csl-entry">

Johnston, J. M., and W. L. Carroll. 1992. “C-Myc Hypermutation in
Burkitt’s Lymphoma.” *Leukemia & Lymphoma* 8 6: 431–39.
<https://doi.org/10.3109/10428199209051025>.

</div>

<div id="ref-khodabakhshiRecurrentTargetsAberrant2012"
class="csl-entry">

Khodabakhshi, Alireza Hadj, Ryan D. Morin, Anthony P. Fejes, Andrew J.
Mungall, Karen L. Mungall, Madison Bolger-Munro, Nathalie A. Johnson, et
al. 2012. “Recurrent Targets of Aberrant Somatic Hypermutation in
Lymphoma.” *Oncotarget* 3 11: 1308–19.
<https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3717795/>.

</div>

<div id="ref-krysiakRecurrentSomaticMutations2017b" class="csl-entry">

Krysiak, Kilannin, Felicia Gomez, Brian S. White, Matthew Matlock,
Christopher A. Miller, Lee Trani, Catrina C. Fronick, et al. 2017.
“Recurrent Somatic Mutations Affecting <span
class="nocase">B-cell</span> Receptor Signaling Pathway Genes in
Follicular Lymphoma.” *Blood* 129 4: 473–83.
<https://doi.org/10.1182/blood-2016-07-729954>.

</div>

<div id="ref-lakeMutationsNFKBIAEncoding2009" class="csl-entry">

Lake, Annette, Lesley A. Shield, Pablo Cordano, Daniel T. Y. Chui, Julie
Osborne, Shauna Crae, Katherine S. Wilson, et al. 2009. “Mutations of
NFKBIA, Encoding IkappaB Alpha, Are a Recurrent Finding in Classical
Hodgkin Lymphoma but Are Not a Unifying Feature of Non-<span
class="nocase">EBV-associated</span> Cases.” *International Journal of
Cancer* 125 6: 1334–42. <https://doi.org/10.1002/ijc.24502>.

</div>

<div id="ref-lenzOncogenicCARD11Mutations2008" class="csl-entry">

Lenz, Georg, R Eric Davis, Vu N Ngo, Lloyd Lam, Thaddeus C George,
George W Wright, Sandeep S Dave, et al. 2008. “Oncogenic CARD11
Mutations in Human Diffuse Large B Cell Lymphoma.” *Science* 319 5870:
1676–79.

</div>

<div id="ref-lohrDiscoveryPrioritizationSomatic2012a" class="csl-entry">

Lohr, Jens G., Petar Stojanov, Michael S. Lawrence, Daniel Auclair,
Bjoern Chapuy, Carrie Sougnez, Peter Cruz-Gordillo, et al. 2012.
“Discovery and Prioritization of Somatic Mutations in Diffuse Large
<span class="nocase">B-cell</span> Lymphoma DLBCL by Whole-Exome
Sequencing.” *Proceedings of the National Academy of Sciences of the
United States of America* 109 10: 3879–84.
<https://doi.org/10.1073/pnas.1121343109>.

</div>

<div id="ref-louissaintPediatrictypeNodalFollicular2016a"
class="csl-entry">

Louissaint, Abner, Kristian T. Schafernak, Julia T. Geyer, Alexandra E.
Kovach, Mahmoud Ghandi, Dita Gratzinger, Christine G. Roth, et al. 2016.
“Pediatric-Type Nodal Follicular Lymphoma: A Biologically Distinct
Lymphoma with Frequent MAPK Pathway Mutations.” *Blood* 128 8:
1093–1100. <https://doi.org/10.1182/blood-2015-12-682591>.

</div>

<div id="ref-loveGeneticLandscapeMutations2012" class="csl-entry">

Love, Cassandra, Zhen Sun, Dereje Jima, Guojie Li, Jenny Zhang, Rodney
Miles, Kristy L. Richards, et al. 2012. “The Genetic Landscape of
Mutations in Burkitt Lymphoma.” *Nature Genetics* 44 12: 1321–25.
<https://doi.org/10.1038/ng.2468>.

</div>

<div id="ref-mareschalWholeExomeSequencing2016" class="csl-entry">

Mareschal, Sylvain, Sydney Dubois, Pierre-Julien Viailly, Philippe
Bertrand, Elodie Bohers, Catherine Maingonnat, Jean-Philippe Jaïs, et
al. 2016. “Whole Exome Sequencing of Relapsed/Refractory Patients
Expands the Repertoire of Somatic Mutations in Diffuse Large <span
class="nocase">B-cell</span> Lymphoma.” *Genes, Chromosomes & Cancer* 55
3: 251–67. <https://doi.org/10.1002/gcc.22328>.

</div>

<div id="ref-morinSomaticMutationsAltering2010a" class="csl-entry">

Morin, Ryan D., Nathalie A. Johnson, Tesa M. Severson, Andrew J.
Mungall, Jianghong An, Rodrigo Goya, Jessica E. Paul, et al. 2010.
“Somatic Mutations Altering EZH2 Tyr641 in Follicular and Diffuse
Large <span class="nocase">B-cell</span> Lymphomas of Germinal-Center
Origin.” *Nature Genetics* 42 2: 181–85.
<https://doi.org/10.1038/ng.518>.

</div>

<div id="ref-morinFrequentMutationHistonemodifying2011"
class="csl-entry">

Morin, Ryan D., Maria Mendez-Lago, Andrew J. Mungall, Rodrigo Goya,
Karen L. Mungall, Richard D. Corbett, Nathalie A. Johnson, et al. 2011.
“Frequent Mutation of Histone-Modifying Genes in Non-Hodgkin Lymphoma.”
*Nature* 476 7360: 298–303. <https://doi.org/10.1038/nature10351>.

</div>

<div id="ref-morinMutationalStructuralAnalysis2013" class="csl-entry">

Morin, Ryan D., Karen Mungall, Erin Pleasance, Andrew J. Mungall,
Rodrigo Goya, Ryan D. Huff, David W. Scott, et al. 2013. “Mutational and
Structural Analysis of Diffuse Large <span class="nocase">B-cell</span>
Lymphoma Using Whole-Genome Sequencing.” *Blood* 122 7: 1256–65.
<https://doi.org/10.1182/blood-2013-02-483727>.

</div>

<div id="ref-mottokIntegrativeGenomicAnalysis2019b" class="csl-entry">

Mottok, Anja, Stacy S. Hung, Elizabeth A. Chavez, Bruce Woolcock, Adèle
Telenius, Lauren C. Chong, Barbara Meissner, et al. 2019. “Integrative
Genomic Analysis Identifies Key Pathogenic Mechanisms in Primary
Mediastinal Large <span class="nocase">B-cell</span> Lymphoma.” *Blood*
134 10: 802–13. <https://doi.org/10.1182/blood.2019001126>.

</div>

<div id="ref-muppidiLossSignalingGa132014b" class="csl-entry">

Muppidi, J., R. Schmitz, Jesse A. Green, Jesse A. Green, Wenming Xiao,
Adrien B. Larsen, S. Braun, et al. 2014. “Loss of Signaling via Gα13 in
Germinal Center B Cell-Derived Lymphoma.” *Nature* 516: 254–58.
<https://doi.org/10.1038/nature13765>.

</div>

<div id="ref-nadeuGenomicEpigenomicInsights2020b" class="csl-entry">

Nadeu, F., D. Martín-García, G. Clot, A. Díaz-Navarro, M. Duran-Ferrer,
A. Navarro, Roser Vilarrasa-Blasi, et al. 2020. “Genomic and Epigenomic
Insights into the Origin, Pathogenesis and Clinical Behavior of Mantle
Cell Lymphoma Subtypes.” *Blood*.
<https://doi.org/10.1182/blood.2020005289>.

</div>

<div id="ref-ngoOncogenicallyActiveMYD882011a" class="csl-entry">

Ngo, Vu N., Ryan M. Young, Roland Schmitz, Sameer Jhavar, Wenming Xiao,
Kian-Huat Lim, Holger Kohlhammer, et al. 2011. “Oncogenically Active
MYD88 Mutations in Human Lymphoma.” *Nature* 470 7332: 115–19.
<https://doi.org/10.1038/nature09671>.

</div>

<div id="ref-okosunRecurrentMTORC1activatingRRAGC2016a"
class="csl-entry">

Okosun, Jessica, Rachel L. Wolfson, Jun Wang, Shamzah Araf, Lucy
Wilkins, Brian M. Castellano, Leire Escudero-Ibarz, et al. 2016.
“Recurrent <span class="nocase">mTORC1-activating RRAGC</span> Mutations
in Follicular Lymphoma.” *Nature Genetics* 48 2: 183–88.
<https://doi.org/10.1038/ng.3473>.

</div>

<div id="ref-oricchioGeneticEpigeneticInactivation2017b"
class="csl-entry">

Oricchio, Elisa, Natalya Katanayeva, Maria Christine Donaldson,
Stephanie Sungalee, Joyce P. Pasion, Wendy Béguelin, Elena Battistello,
et al. 2017. “Genetic and Epigenetic Inactivation of SESTRIN1 Controls
<span class="nocase">mTORC1</span> and Response to EZH2 Inhibition in
Follicular Lymphoma.” *Science Translational Medicine* 9 396:
eaak9969. <https://doi.org/10.1126/scitranslmed.aak9969>.

</div>

<div id="ref-paneaWholeGenomeLandscape2019" class="csl-entry">

Panea, R., C. Love, Jennifer R. Shingleton, Anupama Reddy, J. Bailey, A.
Moormann, J. Otieno, et al. 2019. “The Whole Genome Landscape of Burkitt
Lymphoma Subtypes.” *Blood*. <https://doi.org/10.1182/blood.2019001880>.

</div>

<div id="ref-pararajalingamCodingNoncodingDrivers2020"
class="csl-entry">

Pararajalingam, Prasath, Krysta M. Coyle, Sarah E. Arthur, Nicole
Thomas, Miguel Alcaide, Barbara Meissner, Merrill Boyle, et al. 2020.
“Coding and Noncoding Drivers of Mantle Cell Lymphoma Identified Through
Exome and Genome Sequencing.” *Blood* 136 5: 572–84.
<https://doi.org/10.1182/blood.2019002385>.

</div>

<div id="ref-parryWholeExomeSequencing2013" class="csl-entry">

Parry, Marina, Matthew J. J. Rose-Zerilli, Jane Gibson, Sarah Ennis,
Renata Walewska, Jade Forster, Helen Parker, et al. 2013. “Whole Exome
Sequencing Identifies Novel Recurrently Mutated Genes in Patients with
Splenic Marginal Zone Lymphoma.” *PloS One* 8 12: e83244.
<https://doi.org/10.1371/journal.pone.0083244>.

</div>

<div id="ref-pasqualucciInactivatingMutationsAcetyltransferase2011a"
class="csl-entry">

Pasqualucci, Laura, David Dominguez-Sola, Annalisa Chiarenza, Giulia
Fabbri, Adina Grunn, Vladimir Trifonov, Lawryn H. Kasper, et al. 2011.
“Inactivating Mutations of Acetyltransferase Genes in <span
class="nocase">B-cell</span> Lymphoma.” *Nature* 471 7337: 189–95.
<https://doi.org/10.1038/nature09730>.

</div>

<div id="ref-pasqualucciAnalysisCodingGenome2011" class="csl-entry">

Pasqualucci, Laura, Vladimir Trifonov, Giulia Fabbri, Jing Ma, Davide
Rossi, Annalisa Chiarenza, Victoria A. Wells, et al. 2011. “Analysis of
the Coding Genome of Diffuse Large <span class="nocase">B-cell</span>
Lymphoma.” *Nature Genetics* 43 9: 830–37.
<https://doi.org/10.1038/ng.892>.

</div>

<div id="ref-pasqualucciHypermutationMultipleProtooncogenes2001a"
class="csl-entry">

Pasqualucci, L., P. Neumeister, T. Goossens, G. Nanjangud, R. S.
Chaganti, R. Küppers, and R. Dalla-Favera. 2001. “Hypermutation of
Multiple Proto-Oncogenes in <span class="nocase">B-cell</span> Diffuse
Large-Cell Lymphomas.” *Nature* 412 6844: 341–46.
<https://doi.org/10.1038/35085588>.

</div>

<div id="ref-reddyGeneticFunctionalDrivers2017" class="csl-entry">

Reddy, Anupama, Jenny Zhang, Nicholas S Davis, Andrea B Moffitt,
Cassandra L Love, Alexander Waldrop, Sirpa Leppa, et al. 2017. “Genetic
and Functional Drivers of Diffuse Large B Cell Lymphoma.” *Cell* 171
2: 481–494.e15.

</div>

<div id="ref-reichelFlowSortingExome2015a" class="csl-entry">

Reichel, Jonathan, Amy Chadburn, Paul G. Rubinstein, Lisa Giulino-Roth,
Wayne Tam, Yifang Liu, Rafael Gaiolla, et al. 2015. “Flow Sorting and
Exome Sequencing Reveal the Oncogenome of Primary Hodgkin and
Reed-Sternberg Cells.” *Blood* 125 7: 1061–72.
<https://doi.org/10.1182/blood-2014-11-610436>.

</div>

<div id="ref-richterRecurrentMutationID32012a" class="csl-entry">

Richter, Julia, Matthias Schlesner, Steve Hoffmann, Markus Kreuz, Ellen
Leich, Birgit Burkhardt, Maciej Rosolowski, et al. 2012. “Recurrent
Mutation of the ID3 Gene in Burkitt Lymphoma Identified by Integrated
Genome, Exome and Transcriptome Sequencing.” *Nature Genetics* 44 12:
1316–20. <https://doi.org/10.1038/ng.2469>.

</div>

<div id="ref-ritzRecurrentMutationsSTAT62009a" class="csl-entry">

Ritz, Olga, Chrystelle Guiter, Flavia Castellano, Karola Dorsch, Julia
Melzner, Jean-Philippe Jais, Gwendoline Dubois, Philippe Gaulard, Peter
Möller, and Karen Leroy. 2009. “Recurrent Mutations of the STAT6 DNA
Binding Domain in Primary Mediastinal <span class="nocase">B-cell</span>
Lymphoma.” *Blood* 114 6: 1236–42.
<https://doi.org/10.1182/blood-2009-03-209759>.

</div>

<div id="ref-rossiAlterationBIRC3Multiple2011a" class="csl-entry">

Rossi, Davide, Silvia Deaglio, David Dominguez-Sola, Silvia Rasi,
Tiziana Vaisitti, Claudio Agostinelli, Valeria Spina, et al. 2011.
“Alteration of BIRC3 and Multiple Other <span
class="nocase">NF-κB</span> Pathway Genes in Splenic Marginal Zone
Lymphoma.” *Blood* 118 18: 4930–34.
<https://doi.org/10.1182/blood-2011-06-359166>.

</div>

<div id="ref-rossiCodingGenomeSplenic2012c" class="csl-entry">

Rossi, Davide, Vladimir Trifonov, Marco Fangazio, Alessio Bruscaggin,
Silvia Rasi, Valeria Spina, Sara Monti, et al. 2012. “The Coding Genome
of Splenic Marginal Zone Lymphoma: Activation of NOTCH2 and Other
Pathways Regulating Marginal Zone Development.” *The Journal of
Experimental Medicine* 209 9: 1537–51.
<https://doi.org/10.1084/jem.20120904>.

</div>

<div id="ref-russler-germainMutationsAssociatedProgression2023b"
class="csl-entry">

Russler-Germain, David A., Kilannin Krysiak, Cody A. Ramirez, Matthew
Mosior, Marcus P. Watkins, Felicia Gomez, Zachary L. Skidmore, et al.
2023. “Mutations Associated with Progression in Follicular Lymphoma
Predict Inferior Outcomes at Diagnosis: Alliance A151303.” *Blood
Advances* 7: 5524–39.
<https://doi.org/10.1182/bloodadvances.2023010779>.

</div>

<div id="ref-sarkozyMutationalLandscapeGray2021a" class="csl-entry">

Sarkozy, Clémentine, Stacy S. Hung, Elizabeth A. Chavez, Gerben Duns,
Katsuyoshi Takata, Lauren C. Chong, Tomohiro Aoki, et al. 2021.
“Mutational Landscape of Gray Zone Lymphoma.” *Blood* 137 13: 1765–76.
<https://doi.org/10.1182/blood.2020007507>.

</div>

<div id="ref-schmitzTNFAIP3A20Tumor2009a" class="csl-entry">

Schmitz, Roland, Martin-Leo Hansmann, Verena Bohle, Jose Ignacio
Martin-Subero, Sylvia Hartmann, Gunhild Mechtersheimer, Wolfram Klapper,
et al. 2009. “TNFAIP3 A20 Is a Tumor Suppressor Gene in Hodgkin
Lymphoma and Primary Mediastinal B Cell Lymphoma.” *The Journal of
Experimental Medicine* 206 5: 981–89.
<https://doi.org/10.1084/jem.20090528>.

</div>

<div id="ref-schmitzGeneticsPathogenesisDiffuse2018a" class="csl-entry">

Schmitz, Roland, George W. Wright, Da Wei Huang, Calvin A. Johnson,
James D. Phelan, James Q. Wang, Sandrine Roulland, et al. 2018.
“Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma.” *The New
England Journal of Medicine* 378 15: 1396–1407.
<https://doi.org/10.1056/NEJMoa1801445>.

</div>

<div id="ref-schmitzBurkittLymphomaPathogenesis2012" class="csl-entry">

Schmitz, Roland, Ryan M. Young, Michele Ceribelli, Sameer Jhavar,
Wenming Xiao, Meili Zhang, George Wright, et al. 2012. “Burkitt Lymphoma
Pathogenesis and Therapeutic Targets from Structural and Functional
Genomics.” *Nature* 490 7418: 116–20.
<https://doi.org/10.1038/nature11378>.

</div>

<div id="ref-schollMutationsRegionFAS2007" class="csl-entry">

Scholl, Vanesa, Claudio Gustavo Stefanoff, Rocio Hassan, Nelson Spector,
and Ilana Zalcberg Renault. 2007. “Mutations Within the 5’ Region of
FAS/CD95 Gene in Nodal Diffuse Large <span class="nocase">B-cell</span>
Lymphoma.” *Leukemia & Lymphoma* 48 5: 957–63.
<https://doi.org/10.1080/10428190701230858>.

</div>

<div id="ref-shinBRAFV600EMAP2K12015" class="csl-entry">

Shin, Sang-Yong, Seung-Tae Lee, Hee-Jin Kim, Chang-Seok Ki, Chul Won
Jung, Jong-Won Kim, and Sun-Hee Kim. 2015. “BRAF V600E and MAP2K1
Mutations in Hairy Cell Leukemia and Splenic Marginal Zone Lymphoma
Cases.” *Annals of Laboratory Medicine* 35 2: 257–59.
<https://doi.org/10.3343/alm.2015.35.2.257>.

</div>

<div id="ref-spinaGeneticsNodalMarginal2016b" class="csl-entry">

Spina, Valeria, Hossein Khiabanian, Monica Messina, Sara Monti, Luciano
Cascione, Alessio Bruscaggin, Elisa Spaccarotella, et al. 2016. “The
Genetics of Nodal Marginal Zone Lymphoma.” *Blood* 128 10: 1362–73.
<https://doi.org/10.1182/blood-2016-02-696757>.

</div>

<div id="ref-tanakaFrequentIncidenceSomatic1992" class="csl-entry">

Tanaka, S., D. C. Louie, J. A. Kant, and J. C. Reed. 1992. “Frequent
Incidence of Somatic Mutations in Translocated BCL2 Oncogenes of
Non-Hodgkin’s Lymphomas.” *Blood* 79 1: 229–37.

</div>

<div id="ref-thomasGeneticSubgroupsInform2023" class="csl-entry">

Thomas, Nicole, Kostiantyn Dreval, Daniela S. Gerhard, Laura K. Hilton,
Jeremy S. Abramson, Richard F. Ambinder, Stefan Barta, et al. 2023.
“Genetic Subgroups Inform on Pathobiology in Adult and Pediatric Burkitt
Lymphoma.” *Blood* 141 8: 904–16.
<https://doi.org/10.1182/blood.2022016534>.

</div>

<div id="ref-tiacciPervasiveMutationsJAKSTAT2018b" class="csl-entry">

Tiacci, Enrico, Erik Ladewig, Gianluca Schiavoni, Alex Penson,
Elisabetta Fortini, Valentina Pettirossi, Yuchun Wang, et al. 2018.
“Pervasive Mutations of JAK-STAT Pathway Genes in Classical Hodgkin
Lymphoma.” *Blood* 131 22: 2454–65.
<https://doi.org/10.1182/blood-2017-11-814913>.

</div>

<div id="ref-wenigerMutationsTumorSuppressor2006a" class="csl-entry">

Weniger, M. A., I. Melzner, C. K. Menz, S. Wegener, A. J. Bucur, K.
Dorsch, T. Mattfeldt, T. F. E. Barth, and P. Möller. 2006. “Mutations of
the Tumor Suppressor Gene SOCS-1 in Classical Hodgkin Lymphoma Are
Frequent and Associated with Nuclear Phospho-STAT5 Accumulation.”
*Oncogene* 25 18: 2679–84. <https://doi.org/10.1038/sj.onc.1209151>.

</div>

<div id="ref-wienandGenomicAnalysesFlowsorted2019b" class="csl-entry">

Wienand, Kirsty, Bjoern Chapuy, Chip Stewart, Andrew J. Dunford, David
Wu, Jaegil Kim, Atanas Kamburov, et al. 2019. “Genomic Analyses of
Flow-Sorted Hodgkin Reed-Sternberg Cells Reveal Complementary Mechanisms
of Immune Evasion.” *Blood Advances* 3 23: 4065–80.
<https://doi.org/10.1182/bloodadvances.2019001012>.

</div>

<div id="ref-wildaInactivationARFMDM2p53Pathway2004" class="csl-entry">

Wilda, M., J. Bruch, L. Harder, D. Rawer, A. Reiter, A. Borkhardt, and
W. Woessmann. 2004. “Inactivation of the <span
class="nocase">ARF-MDM-2-p53</span> Pathway in Sporadic Burkitt’s
Lymphoma in Children.” *Leukemia* 18 3: 584–88.
<https://doi.org/10.1038/sj.leu.2403254>.

</div>

<div id="ref-wuGeneticHeterogeneityPrimary2016" class="csl-entry">

Wu, Chenglin, Noel Fcc de Miranda, Longyun Chen, Agata M. Wasik, Larry
Mansouri, Wojciech Jurczak, Krystyna Galazka, et al. 2016. “Genetic
Heterogeneity in Primary and Relapsed Mantle Cell Lymphomas: Impact of
Recurrent CARD11 Mutations.” *Oncotarget* 7 25: 38180–90.
<https://doi.org/10.18632/oncotarget.9500>.

</div>

<div id="ref-yanBCRTLRSignaling2012a" class="csl-entry">

Yan, Qingguo, Yuanxue Huang, A. James Watkins, Sylvia Kocialkowski,
Naiyan Zeng, Rifat A. Hamoudi, Peter G. Isaacson, Laurence de Leval,
Andrew Wotherspoon, and Ming-Qing Du. 2012. “BCR and TLR Signaling
Pathways Are Recurrently Targeted by Genetic Changes in Splenic Marginal
Zone Lymphomas.” *Haematologica* 97 4: 595–98.
<https://doi.org/10.3324/haematol.2011.054080>.

</div>

<div id="ref-yildizActivatingSTAT6Mutations2015c" class="csl-entry">

Yildiz, Mehmet, Hongxiu Li, Denzil Bernard, Nisar A. Amin, Peter
Ouillette, Siân Jones, Kamlai Saiya-Cork, et al. 2015. “Activating STAT6
Mutations in Follicular Lymphoma.” *Blood* 125 4: 668–79.
<https://doi.org/10.1182/blood-2014-06-582650>.

</div>

<div id="ref-zhangGeneticHeterogeneityDiffuse2013" class="csl-entry">

Zhang, Jenny, Vladimir Grubor, Cassandra L Love, Anjishnu Banerjee,
Kristy L Richards, Piotr A Mieczkowski, Cherie Dunphy, et al. 2013.
“Genetic Heterogeneity of Diffuse Large <span
class="nocase">B-cell</span> Lymphoma.” January.

</div>

</div>
